Structure of 85 kDa Subunit of Human Phosphatidylinositol 3‐Kinase Analyzed by Using Monoclonal Antibodies
An 85 kDa subunit (p85α) of phosphatidylinositol 3‐kinase (PI‐3K) has one SH3 and two SH2 regions [SH2(N) and SH2(C)], which direct protein‐protein interaction. We have established eighteen hybridomas producing monoclonal antibodies against p85α to study the structure‐function relationship of this p...
Saved in:
Published in | Cancer science Vol. 84; no. 3; pp. 279 - 289 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.03.1993
Japanese Cancer Association John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An 85 kDa subunit (p85α) of phosphatidylinositol 3‐kinase (PI‐3K) has one SH3 and two SH2 regions [SH2(N) and SH2(C)], which direct protein‐protein interaction. We have established eighteen hybridomas producing monoclonal antibodies against p85α to study the structure‐function relationship of this protein. Epitope mapping using a series of deletion mutants expressed in E. coli showed that the monoclonal antibodies bound to at least 5 distinct epitope regions, which were well dispersed on p85α except for its carboxyl‐terminus. Monoclonal antibodies against ammo‐terminal regions and polyclonal antibodies against carboxyl‐terminal regions immunoprecipitated p85α expressed in human cells and in E. coli. On the other hand, monoclonal antibodies against the central part of p85α failed to immunoprecipitate p85α efficiently; however, they could immunoprecipitate p85α mutants with deletion of either the amino‐ or the carboxyl‐terminal region. Similar results were obtained by immunocytochemistry using confocal microscopy. These results suggested that steric hindrance prevents binding of monoclonal antibodies to the central part of p85α where SH2(N) is located. The SH2(N) may have a distinct function from SH2(C), which is located at the carboxyl‐terminal region and has been shown to mediate the binding of PI‐3K to activated growth factor receptors. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0910-5050 1347-9032 1349-7006 1876-4673 |
DOI: | 10.1111/j.1349-7006.1993.tb02868.x |